Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era

Maturitas

Volumn 52, Issue 1, 2005, Pages 18-25

  Nassar, Anwar H ^a   Abd Essamad, Hasan M ^a   Awwad, Johnny T ^a   Khoury, Nabil G ^a   Usta, Ihab M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Gynecologists practices; Hormone therapy; WHI study

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; TIBOLONE;

ADULT; ALTERNATIVE MEDICINE; ARAB; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG USE; FEMALE; HORMONAL THERAPY; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL SPECIALIST; PATIENT; PATIENT COUNSELING; PATIENT INFORMATION; PHYSICIAN ATTITUDE; POSTAL MAIL; POSTMENOPAUSE; QUESTIONNAIRE; RISK REDUCTION; SAMPLE; STATISTICAL ANALYSIS;

ADULT; ATTITUDE OF HEALTH PERSONNEL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; GYNECOLOGY; HUMANS; LEBANON; MALE; MEDROXYPROGESTERONE 17-ACETATE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS;

EQUIDAE;

EID: 24144490656     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.03.008     Document Type: Conference Paper

References (16)

1. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
2. D. Grady A 60-year-old woman trying to discontinue hormone replacement therapy JAMA 287 2002 2130 2137
3. G. Kolata FDA orders warning on all estrogen labels New York Times 9 2003 18
4. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. U.S. Preventive Services Task Force. Ann Int Med 2002; 137: 834-9.
5. American College of Obstetricians and Gynecologists. Guidelines for women's health care. Washington, DC: The College; 2002.
6. B. Ettinger, D. Grady, A.N. Tosteson, A. Pressman, and J.L. Macer Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy Obstet Gynecol 102 2003 1225 1232
7. J.E. Blumel, C. Castelo-Branco, and P.A. Chedraui Patients' and clinicians' attitudes after the Women's Health Initiative study Menopause 11 2004 57 61
8. J.S. Hass, C.P. Kaplan, E.P. Gerstenberger, and K. Kerlikowske Changes in the use of post-menopausal hormone therapy after the publication of clinical trial results Ann Intern Med 140 2004 184 188
9. G. Ena, and S. Rozenberg Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study Hum Reprod 18 2003 2245 2248
10. V. Beral Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
11. G.L. Anderson, M. Limacher, and A.R. Assaf Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
12. C. Antoine, F. Liebens, B. Carly, A. Pastijn, and S. Rozenberg Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial Hum Reprod 19 2004 741 756
13. S. Hulley, D. Grady, C. Furberg, D. Herrington, B.L. Riggs, and E. Vittinghoff Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
14. L. Speroff WHI trial: it's time to be critical! Am J Obstet Gynecol 189 2003 620
15. W.T. Creasman, D. Hoel, and P.J. Disaia WHI: Now that the dust has settled: a commentary Am J Obstet Gynecol 189 2003 621 626
16. D. Ketley, and K.L. Woods Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction Lancet 342 1993 891 894